NasdaqGM:NSTG

Stock Analysis Report

Executive Summary

NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide.

Snowflake

Fundamentals

Adequate balance sheet with concerning outlook.


Similar Companies

Share Price & News

How has NanoString Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0.9%

NSTG

0.4%

US Life Sciences

0.4%

US Market


1 Year Return

41.5%

NSTG

13.5%

US Life Sciences

6.9%

US Market

Return vs Industry: NSTG exceeded the US Life Sciences industry which returned 13.5% over the past year.

Return vs Market: NSTG exceeded the US Market which returned 6.9% over the past year.


Shareholder returns

NSTGIndustryMarket
7 Day0.9%0.4%0.4%
30 Day-5.1%-4.3%-1.2%
90 Day-32.5%-3.8%-0.4%
1 Year41.5%41.5%13.7%13.5%9.3%6.9%
3 Year6.4%6.4%78.4%76.9%45.8%36.4%
5 Year104.5%104.5%111.6%102.1%62.9%45.1%

Price Volatility Vs. Market

How volatile is NanoString Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is NanoString Technologies undervalued compared to its fair value and its price relative to the market?

8.82x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate NSTG's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate NSTG's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: NSTG is unprofitable, so we can't compare its PE Ratio to the Life Sciences industry average.

PE vs Market: NSTG is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate NSTG's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NSTG is overvalued based on its PB Ratio (8.8x) compared to the US Life Sciences industry average (4.5x).


Next Steps

Future Growth

How is NanoString Technologies forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

23.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NSTG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NSTG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NSTG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NSTG's revenue (14.2% per year) is forecast to grow faster than the US market (7.2% per year).

High Growth Revenue: NSTG's revenue (14.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: NSTG is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has NanoString Technologies performed over the past 5 years?

-9.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: NSTG is unprofitable, and losses have increased over the past 5 years at a rate of -9.9% per year.

Accelerating Growth: Unable to compare NSTG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NSTG is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (45%).


Return on Equity

High ROE: NSTG has a negative Return on Equity (-92.49%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: NSTG is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: NSTG is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is NanoString Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: NSTG's short term assets ($190.1M) exceeds its short term liabilities ($36.5M)

Long Term Liabilities: NSTG's short term assets (190.1M) exceeds its long term liabilities (110.4M)


Debt to Equity History and Analysis

Debt Level: NSTG's debt to equity ratio (91.2%) is considered high

Reducing Debt: NSTG's debt to equity ratio has increased from 31% to 91.2% over the past 5 years.


Balance Sheet

Inventory Level: NSTG has a high level of physical assets or inventory.

Debt Coverage by Assets: NSTG's debt is covered by short term assets (assets are 2.423660x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NSTG has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NSTG has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -47.4% each year


Next Steps

Dividend

What is NanoString Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage0.4%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate NSTG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate NSTG's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if NSTG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NSTG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NSTG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of NanoString Technologies's salary, the management and board of directors tenure and is there insider trading?

6.0yrs

Average management tenure


CEO

Brad Gray (42yo)

9.3yrs

Tenure

US$2,527,985

Compensation

Mr. R. Bradley Gray, also known as Brad, has been the Chief Executive Officer and President of NanoString Technologies, Inc. since June 29, 2010. Mr. Gray worked at Genzyme Genetics, the diagnostic service ...


CEO Compensation Analysis

Compensation vs. Market: Brad's total compensation ($USD2.53M) is about average for companies of similar size in the US market ($USD2.69M).

Compensation vs Earnings: Brad's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

6.0yrs

Average Tenure

56yo

Average Age

Experienced Management: NSTG's management team is seasoned and experienced (6 years average tenure).


Board Age and Tenure

7.3yrs

Average Tenure

58yo

Average Age

Experienced Board: NSTG's board of directors are considered experienced (7.3 years average tenure).


Insider Trading

Insider Buying: NSTG insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$37,13013 Sep 19
Charles Waite
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,707
Max PriceUS$21.75
SellUS$43,240,00022 Mar 19
Clarus Ventures, LLC
EntityCompany
Shares2,000,000
Max PriceUS$21.62

Ownership Breakdown


Management Team

  • Kathy Surace-Smith (60yo)

    VP, General Counsel & Corporate Secretary

    • Tenure: 6.7yrs
  • J. Brown (61yo)

    Senior Vice President of Sales & Marketing

    • Tenure: 2.3yrs
    • Compensation: US$1.08m
  • Tom Bailey (50yo)

    CFO & Treasurer

    • Tenure: 1.8yrs
    • Compensation: US$1.40m
  • Doug Farrell

    Vice President of Investor Relations & Corporate Communications

    • Tenure: 3.1yrs
  • Debbie Krogman

    Vice President of Human Resources

    • Tenure: 6yrs
  • Mary Allen (56yo)

    Senior Vice President of Strategic Initiatives

    • Tenure: 0yrs
    • Compensation: US$896.35k
  • Brad Gray (42yo)

    CEO, President & Director

    • Tenure: 9.3yrs
    • Compensation: US$2.53m
  • Joe Beechem (61yo)

    Senior Vice President of Research & Development

    • Tenure: 7.5yrs
    • Compensation: US$1.07m
  • David Ghesquiere (52yo)

    Senior Vice President of Corporate & Business Development

    • Tenure: 5.9yrs
    • Compensation: US$1.04m
  • Mark Winham

    Senior Vice President of Operations

    • Tenure: 0yrs

Board Members

  • Bill Young (74yo)

    Independent Chairman

    • Tenure: 9.8yrs
    • Compensation: US$132.86k
  • Elisha Finney (58yo)

    Independent Director

    • Tenure: 2.4yrs
    • Compensation: US$87.86k
  • Chad Waite (63yo)

    Independent Director

    • Tenure: 15.3yrs
    • Compensation: US$97.86k
  • Rob Hershberg (57yo)

    Independent Director

    • Tenure: 4.6yrs
    • Compensation: US$85.36k
  • Kirk Malloy (52yo)

    Independent Director

    • Tenure: 3.1yrs
    • Compensation: US$86.36k
  • Greg Norden (61yo)

    Independent Director

    • Tenure: 7.3yrs
    • Compensation: US$104.36k
  • Brad Gray (42yo)

    CEO, President & Director

    • Tenure: 9.3yrs
    • Compensation: US$2.53m
  • Chad Nusbaum

    Member of Sequencing Advisory Board

    • Tenure: 0yrs

Company Information

NanoString Technologies, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: NanoString Technologies, Inc.
  • Ticker: NSTG
  • Exchange: NasdaqGM
  • Founded: 2003
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$760.275m
  • Shares outstanding: 35.44m
  • Website: https://www.nanostring.com

Number of Employees


Location

  • NanoString Technologies, Inc.
  • 530 Fairview Avenue North
  • Seattle
  • Washington
  • 98109
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NSTGNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDJun 2013
0F1DB (Deutsche Boerse AG)YesCommon StockDEEURJun 2013

Biography

NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-applicatio ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/19 00:30
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.